Most Read Articles
14 Sep 2019
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.
15 Sep 2019
Podcast: Dr Shamir Mehta briefly discusses the clinical impact of findings from the COMPLETE trial
16 Sep 2019
Podcast: Prof Derek Chew explains the importance of a 1-hour troponin T protocol in suspected ACS as discussed in the RAPID-TnT trial
15 Sep 2019
Sodium-glucose transport protein 2 (SGLT2) inhibitors exert a putative epigenetic regulation of the protecting cardiovascular effect, reports a study, adding that dapagliflozin may protect the kidneys by preserving renal vasodilating capacity.

Peanut, almond, fine nut consumption beneficial against metabolic syndrome

18 Aug 2019

Eating a relatively small amount of peanut, almond and pine nut may protect against the risk of developing metabolic syndrome (MetS), and the benefit differs by sex and age, a study from Korea has found.

The study population comprised 2,684 men (mean age, 50.9 years) and 2,622 women (mean age, 50.3 years) who were grouped according to their peanut, almond and fine nut intake (<1 serving/month, 1/month–0.5/week, 0.5–1/week, and ≥1/week; one serving corresponds to 15 g) and followed for up to 10 years.

More than half of the men (55.7 percent) and two-thirds of the women (69.3 percent) consumed peanuts, pine nuts and almonds less than once a month, with only 11.9 percent and 8.6 percent reporting having more than one serving per week, respectively. The average consumption was 6.6 g/week in men and 5.1 g/week in women.

Multivariable Cox proportional hazard analysis revealed a significant inverse association between consumption of peanut, pine nut and almond and the incidence of MetS. Furthermore, there was a clear dose-response pattern, with the greatest protective benefit seen among men and women in the highest intake category.

In men, the hazard ratios (HRs; vs <1/month intake category) were 0.91 (95 percent CI, 0.76–1.09) in the 1/month–0.5/week, 1.03 (0.80–1.31) in the 0.5–1/week and 0.72 (0.56–0.93) in the ≥1/week intake category. The corresponding HRs in women were 0.81 (0.65–1.003), 0.76 (0.54–1.07) and 0.57 (0.41–0.79).

Subgroup analysis showed that the protective benefit of peanut, pine nut and almond intake against MetS risk varied by sex and age and was more pronounced in middle-aged men eating ≥1 serving/week and in old-aged women consuming ≥0.5 serving/week.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
14 Sep 2019
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.
15 Sep 2019
Podcast: Dr Shamir Mehta briefly discusses the clinical impact of findings from the COMPLETE trial
16 Sep 2019
Podcast: Prof Derek Chew explains the importance of a 1-hour troponin T protocol in suspected ACS as discussed in the RAPID-TnT trial
15 Sep 2019
Sodium-glucose transport protein 2 (SGLT2) inhibitors exert a putative epigenetic regulation of the protecting cardiovascular effect, reports a study, adding that dapagliflozin may protect the kidneys by preserving renal vasodilating capacity.